About Jill Carroll
Jill Carroll is a director at Avalyn Pharma.
Jill Carroll reports to the SEC as a director or major shareholder of 4 public companies, including Arcellx (ACLX), Pandion Therapeutics (PAND) and Applied Genetic Technologies (AGTC).
Jill Carroll first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Jill Carroll in the role, so the role may have started earlier or lasted longer.
AI
Arcellx, Inc.
Director
2022 – 2026 · Public company (ACLX)
PI
Pandion Therapeutics, Inc.
Director and 10% owner
2020 – 2021 · Public company (PAND)
AC
Applied Genetic Technologies Corp.
Director and 10% owner
2014 · Public company (AGTC)
Key Colleagues at Startups
The people Jill Carroll works with at each company, as listed on that company's latest Form D.
Avalyn Pharma Inc. · Form D, Oct 10, 2023
LB
Lyn Baranowski
Chief Executive Officer and director
TA
Tiba Aynechi
Director
KP
Ketan Patel
Director
PM
Peter Moldt
Director
ND
Niall O'Donnell
Director
CL
Cassandra Luca
Director
JL
Jonathan Leff
Director